XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.16

-3.2%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (9530)	4/5/1999 4:36:00 PM
From: Cacaito	Read Replies (1) of 17367

Bluegreen, I do not have any further ideas for "possible" lower mortality, a very low mortality in Bpi group could be one The zero option is too exuberant for serious money talk, I invest the old way with my money (got to work hard for it) and not a chance of getting a florless conversion to protect my shorting. I want the accruals to keep going for a total of 600 to 800 subjects, to ensure bpi will be proven effective or not without doubts. Cloning the Dolly way was conceptualized 50 years ago, what was needed was a vry small driller (it seems they got one) and gently placing DNA in an empty ovule (via the same hole that emptied it out to begin with) and gently enough to get it going. Very clever to use the ovule own mechanisms (nature ready) to do the job. The cloning that is tough is to actually do it the way Geron is trying to, getting stem cells to clone either a full organ or even certain tissues, forget a full animal (men/women included) this way will be very useful, and troubleful in the ethics field. So far they are happy spending $ millions multiplying stem cells 25 times. One need couple of trillions multiplication.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next